CN1314800C - Fixation method of microbiological lactase and its application - Google Patents
Fixation method of microbiological lactase and its application Download PDFInfo
- Publication number
- CN1314800C CN1314800C CNB2005100804920A CN200510080492A CN1314800C CN 1314800 C CN1314800 C CN 1314800C CN B2005100804920 A CNB2005100804920 A CN B2005100804920A CN 200510080492 A CN200510080492 A CN 200510080492A CN 1314800 C CN1314800 C CN 1314800C
- Authority
- CN
- China
- Prior art keywords
- lactose
- lactase
- milk
- immobilized
- xylanase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 108010005774 beta-Galactosidase Proteins 0.000 title claims abstract description 35
- 102100026189 Beta-galactosidase Human genes 0.000 title claims abstract description 33
- 108010059881 Lactase Proteins 0.000 title claims abstract description 33
- 229940116108 lactase Drugs 0.000 title claims abstract description 33
- 230000002906 microbiologic effect Effects 0.000 title description 2
- 239000008267 milk Substances 0.000 claims abstract description 46
- 235000013336 milk Nutrition 0.000 claims abstract description 46
- 210000004080 milk Anatomy 0.000 claims abstract description 46
- 239000011347 resin Substances 0.000 claims abstract description 36
- 229920005989 resin Polymers 0.000 claims abstract description 36
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 15
- 238000001179 sorption measurement Methods 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 7
- 235000010413 sodium alginate Nutrition 0.000 claims description 7
- 239000000661 sodium alginate Substances 0.000 claims description 7
- 229940005550 sodium alginate Drugs 0.000 claims description 7
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000003431 cross linking reagent Substances 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 abstract description 47
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 41
- 108090000790 Enzymes Proteins 0.000 abstract description 28
- 102000004190 Enzymes Human genes 0.000 abstract description 28
- 230000007062 hydrolysis Effects 0.000 abstract description 20
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 20
- 108010093096 Immobilized Enzymes Proteins 0.000 abstract description 16
- 238000004132 cross linking Methods 0.000 abstract description 3
- 241000235058 Komagataella pastoris Species 0.000 abstract description 2
- 239000011942 biocatalyst Substances 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 230000003100 immobilizing effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 27
- 239000000243 solution Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 201000010538 Lactose Intolerance Diseases 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000274 adsorptive effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241000131314 Aspergillus candidus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 244000253911 Saccharomyces fragilis Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- JEHCHYAKAXDFKV-UHFFFAOYSA-J lead tetraacetate Chemical compound CC(=O)O[Pb](OC(C)=O)(OC(C)=O)OC(C)=O JEHCHYAKAXDFKV-UHFFFAOYSA-J 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- GKQAMYKQNHQPDJ-UHFFFAOYSA-K potassium disodium hydrogen phosphate 2-hydroxy-2-oxoacetate Chemical compound P(=O)([O-])([O-])[O-].[Na+].[Na+].C(C(=O)O)(=O)O.[K+] GKQAMYKQNHQPDJ-UHFFFAOYSA-K 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
本发明涉及一种乳糖酶的固定化方法及固定化乳糖酶的应用。该发明利用发明人筛选得到的树脂作为载体吸附固定用重组毕赤酵母发酵得到过滤清液中的胞外游离乳糖酶；再将这种吸附了酶的载体用海藻酸钙包埋方法与戊二醛交联方法处理，制备成高结合强度的固定化乳糖酶。以该方法制备的固定化乳糖酶作为生物催化剂水解5%乳糖溶液，固定化酶用量为10～100%(w/v)，5～60℃下作用0.5～1小时，连续转化52批，乳糖水解率保持在75%以上；以该方法制备的固定化乳糖酶处理新鲜牛奶，5～60℃下转化0.2～8小时，连续转化30批，乳糖水解率保持在70%以上。The invention relates to a method for immobilizing lactase and the application of the immobilized lactase. In this invention, the resin obtained by the inventor's screening is used as a carrier to absorb and immobilize the extracellular free lactase in the filtered supernatant by fermenting recombinant Pichia pastoris; The aldehyde cross-linking method is used to prepare immobilized lactase with high binding strength. The immobilized lactase prepared by this method is used as a biocatalyst to hydrolyze 5% lactose solution. The amount of immobilized enzyme is 10-100% (w/v), and it acts at 5-60°C for 0.5-1 hour to continuously convert 52 batches of lactose. The hydrolysis rate is kept above 75%; fresh milk is treated with immobilized lactase prepared by this method, converted at 5-60°C for 0.2-8 hours, 30 batches are continuously converted, and the lactose hydrolysis rate is kept above 70%.
Description
Technical field
The present invention relates to a kind of process for fixation of enzyme, relate in particular to a kind of process for fixation of microorganism extracellular lactase and immobilized lactase and the application of this immobilized lactase in producing low-lactose milk for preparing by this method.
Background technology
(β-D-galactoside galactohydrolase EC3.2.1.23) is commonly called Sumylact L to beta-galactosidase enzymes.This enzyme can be semi-lactosi and glucose with lactose hydrolysis, and has the transferance of galactoside.
Lactose is formed by a part alpha-D-glucose and a part β-D-semi-lactosi condensation, is to be the β-D-galactoside of aglycon with glucose.Lactose is the main component in milk and the whey, and lactose accounts for 30% of milk dry-matter, influences local flavor.Many people are difficult to pegnin (different because of ethnic group, West Europe accounts for 2～8%, and Asia, Africa account for 60～90%) because of lacking Sumylact L in the body, behind the milk drink, lactose has arrived in the intestines, by the intestinal bacteria decomposing and fermenting, produce great amount of carbon dioxide gas, enteron aisle is expanded, and excited intestines peristalsis, make and shrink to strengthen, cause borborygmus and diarrhoea, this disease is called lactose intolerance, and (the GG uncle is strange etc., enzyme and food-processing, light industry press, 1991, p93～110).
Producing low-lactose milk and milk-product is the effective ways that solve lactose intolerance.The method of removing lactose or production low-lactose milk has three kinds: physical removal method, acid-hydrolysis method and enzyme hydrolysis method.
(1) physical removal method: adopt ultra-filtration technique to remove lactose, though most of lactose can be removed, VITAMIN and mineral substance be loss thereupon also, has to they be added after removing lactose again, and this has also caused the significant wastage of lactose.
(2) acid hydrolyzation be under extreme conditions (pH1～2,100～150 ℃ of temperature) with the lactose in free acid or the ion exchange resin hydrating solution.Although acid hydrolyzation can obtain high conversion at short notice, it can cause the albumen inactivation, can form some by products, can not be used for hydrolysed milk, and acid system needs corrosion resistant equipment, and is also unfavorable to environment.
(3) the enzyme hydrolysis method condition relatively relaxes (pH3.5～8, temperature 5-60 ℃).It is to use the external source Sumylact L the monose of lactose degradation for easily being absorbed by the body and utilizing.Adopt this method, product is simple, and mouthfeel is good, can not destroy other nutritive ingredient in the milk, is the good method that adopts in milk-product processing at present.
Sumylact L is decomposed into glucose, the semi-lactosi that easily is absorbed by the body and utilizes with lactose, can solve the problem of lactose intolerance edible for patients milk-product.In addition, Sumylact L can also be improved the quality of milk-product and produce oligomeric galactose.Oligomeric galactose has the bifidus bacillus increment factor and relative physiological function as functional oligose: low sugariness is low in calories, and low carious tooth can be improved lipid metabolism, improves absorbing of mineral element.
Sumylact L extensively is present in plant, animal, the microorganism.Its potentiality in diary processing was known to the people at the beginning of last century.The sixties, commercially produce by the Sumylact L that extracts in the microorganism.At present, commercial Sumylact L is mainly derived from aspergillus niger, aspergillus oryzae, Kluyveromyces lactis and Crewe dimension saccharomyces fragilis etc.The preparation of free Sumylact L need be extracted Sumylact L usually in the prior art from cell, causes the unit output of Sumylact L lower.Biological Technology institute, Chinese Academy of Agricultural Sciences etc. have developed a kind of new lactase, from Aspergillus candidus CGMCC3.2919, be isolated and cloned into the Sumylact L encoding gene, utilize bio-reactor pichia spp (Pichia pastoris) to efficiently express, its expression product is secreted outside born of the same parents, and Sumylact L is lived and is 3600u/mL; It is proteic more than 90% that fermentative production Sumylact L albumen accounts in the fermented liquid total secretion, and foreign protein content seldom; Solved the defective that needs from cell, to extract Sumylact L in the prior art, improved the unit output of Sumylact L greatly, thereby (Chinese patent application CN 02108141.7, the open date: on October 8th, 2003) for a new way has been opened up in the production of Sumylact L Product industrialization.
When resolvase is used for foodstuffs industry, can cause foreign protein to pollute.Simultaneously, resolvase can't be recycled, and makes production cost improve.Compare with resolvase, immobilized enzyme has following advantage: (1) tool is physical strength preferably, can act under the mode that stirs or adorn post; (2) can be used for suitability for industrialized production, adapt to the requirement of serialization, automatic production; (3) product purity height, side reaction are few, so productive rate is higher; (4) can use repeatedly.Improve the utilization ratio of enzyme, reduced production cost.
The seventies in last century, Italy prepares immobilized lactase with cellulose acetate and has successfully realized the production of low-lactose milk (F.Morisi, Jouranl of dairy science, 1972,56 (9), 1123-1127; 57 (3), 269-272).But use chloroform and toluene in the immobilized enzyme preparation process, these two kinds of organic solvents are used for foodstuffs industry to make us and can't accept.The U.S. (United States Patent (USP) 4,748,121), Japan's (Japanese Patent 56051984) have also reported the immobilization of Sumylact L, but the preparing carriers complexity in the United States Patent (USP) needs in the Japanese technology Sumylact L in the extracellular microbial is extracted.People such as domestic Luo Cheng ancient term for country school, Qin Yan, king's oats orchid have carried out the trial that immobilized lactase is produced low-lactose milk, or with embedded immobilizations such as carrageenins, or with cotton fibre absorption glutaraldehyde cross-linking method, or, all be not suitable for the immobilization of microorganism extracellular lactase with permeability cell Sumylact L and tubular fibre biochemical reactor.
Summary of the invention
Technical problem to be solved by this invention is to overcome the deficiencies in the prior art, and a kind of process for fixation of new microorganism extracellular lactase is provided.
Technical problem to be solved by this invention realizes by following technological approaches:
A kind of process for fixation of microorganism extracellular lactase may further comprise the steps:
(1) prepares the outer free milk xylanase of born of the same parents by art methods;
(2) free milk xylanase is adsorbed on the macroporous resin that pore diameter range is 80～200 ;
(3) macroporous resin that will adsorb enzyme soaks with sodium alginate soln, stirs, and leaches, and carries out embedding treatment again;
(4) through the macroporous resin cross-linking reagent of embedding treatment,, leach in will step (3), promptly get immobilized enzyme at 4～20 ℃ times crosslinked 1～4 hour.
In the said fixing method, wherein the outer free milk xylanase of the born of the same parents described in the step (1) can adopt that any one method prepares in the prior art, and can select application number as a reference for use is that the disclosed method of patent application of CN 02108141.7 prepares.Adsorption method described in the step (2) is: every 1g resin adds the Sumylact L liquid of 100～500 units, and adsorption temp is 10～50 ℃, and the vibration adsorption time is 1～4 hour.The aperture of the macroporous resin described in the step (2) is preferably 100～120 .The weight percent concentration of the sodium alginate soln described in the step (3) is preferably 1%～5%; Carry out the used reagent of embedding treatment and be selected from CaCl
2Solution, carrageenin or gelatin are preferably the CaCl that concentration is 0.1～1.0mol/L
2Solution.It is 0.25%～2.5% glutaraldehyde that cross-linking reagent described in the step (4) is preferably weight percent concentration.
Used macroporous resin all can be bought from market and obtain among the present invention, as long as pore diameter range is 80～200 , use of the present invention be can satisfy, macroporous resin D001, D001-CC, D061, D113, DA201, HPD600, HPD300, HPD100A, D202 of following model etc. for example can be selected for use.
The present invention as Sumylact L immobilization absorption carrier, obtains the immobilized lactase of excellent property with common commercial resins through simple embedding, crosslinking Treatment.The entire operation process does not need Sumylact L is carried out loaded down with trivial details extraction and purification step, makes production cost greatly descend.Simultaneously, the operational stability of immobilized enzyme is fine.Utilize preparation technology of the present invention, can realize effective immobilization of Sumylact L; After measured, the enzyme work of the immobilized lactase that process for fixation of the present invention is prepared is greater than 70～100u/g, and enzyme yield 50%～60% alive can be directly used in the production of low-lactose milk.
As biological catalyst hydrolysis 5% lactose solution, the immobilized enzyme consumption is 10%～100%, 30 ℃ of effect 0.5～10h down with the immobilized lactase of the inventive method preparation, and lactose hydrolysis ratio transforms more than 50 batches continuously more than 80%.Handle fresh milk (wherein lactose-content 3%～6%) with this immobilized lactase, 5～60 ℃ transform 0.2～8 hour down, and lactose hydrolysis ratio is 70～80%, and the production efficiency of unit immobilization enzyme-treated milk is 1.25L/gh.
Further illustrate beneficial effect of the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never limit the scope of the invention.
Embodiment
Illustrate: remove specified otherwise among the application, used solution is the aqueous solution.
The measuring method of work of Sumylact L enzyme and lactose-content:
Free lactose activity determination method: the Sumylact L enzyme liquid 1mL that gets suitable dilution, 30 ℃ are incubated 2 minutes, add 10mL5% (g/100mL) lactose solution, and 30 ℃ of reactions are after 15 minutes, the variation of lactose-content before and after 10 minutes termination reactions of boiling water bath, assaying reaction.Under 30 ℃, the required enzyme amount of Sumylact L per minute hydrolysis 1 μ mol lactose is an enzyme unit (u) alive.
The immobilized lactase activity determination method: get the 0.5g immobilized lactase, add 25mL5% (g/00mL) lactose solution, 30 ℃ of reactions extracted reaction solution and carry out 10 minutes termination reactions of boiling water bath after 15 minutes, the variation of lactose-content before and after the assaying reaction.Under 30 ℃, the required enzyme amount of Sumylact L per minute hydrolysis 1 μ mol lactose is an enzyme unit (u) alive.
Lactose content measuring method: HPLC measures lactose-content, equipment used is: Agillent 1100 high performance liquid chromatographs, differential refraction detector, stationary phase is Agilent Zorbax CarbohydrateAnalysis Column, moving phase is formed, acetonitrile: water=70: 30, flow velocity 0.5mL/min.The lactose appearance time is 18.098min.With the peak height is quantitative criterion.
Treatment process in the milk before the lactose content measuring: get 2mL milk in the 10mL volumetric flask, add 1mL 20% plumbic acetate solution, shake up; Add 1mL potassium oxalate-disodium phosphate soln (3g potassium oxalate and 7g Sodium phosphate dibasic are dissolved in the 100mL water formulated) again, shake up constant volume; Leave standstill after 30 minutes with dry filter paper and filter, 0.45 μ m filter membrane handles after lactose-content in the HPLC analytic sample.
Embodiment 1
According to number of patent application is that the disclosed method of patent application of CN 02108141.7 prepares the extracellular free milk xylanase; With pore diameter range is that the macroporous resin D113 of 100～120 is the Sumylact L absorption carrier, immobilization technology is: resin demand is the outer free milk xylanase enzyme liquid of born of the same parents that every 1g resin adds 200 units, 10 ℃ of adsorption temps, vibration adsorption time 4 hours, leach the resin of adsorptive enzyme, add concentration and be in 2% the sodium alginate soln and stir, leach, place 0.1mol/L CaCl
2Soaked in the solution 5 minutes, and leached resin, add again in the glutaraldehyde of concentration 2.5%, under 4 ℃ of temperature, left standstill crosslinked 1 hour.Measure the immobilized enzyme 91u/g of being alive, enzyme yield alive is 56.88%.
Embodiment 2
According to number of patent application is that the disclosed method of patent application of CN 02108141.7 prepares the extracellular free milk xylanase; With pore diameter range is that the macroporous resin D001-CC of 80～120 is the Sumylact L absorption carrier, immobilization technology is: resin demand is the outer free milk xylanase enzyme liquid of born of the same parents that every 1g resin adds 100 units, 35 ℃ of adsorption temps, vibration adsorption time 2 hours, leach the resin of adsorptive enzyme, add concentration and be in 5% the sodium alginate soln and stir, leach, place 1mol/L CaCl
2Soaked in the solution 5 minutes, and leached resin, add concentration again and be in 0.25% the glutaraldehyde, under 20 ℃ of temperature, left standstill crosslinked 3 hours.Measure the immobilized enzyme 94u/g of being alive, enzyme yield alive is 58.98%.
Embodiment 3
According to number of patent application is that the disclosed method of patent application of CN 02108141.7 prepares the extracellular free milk xylanase; With pore diameter range is that the macroporous resin HPD300 of 100～120 is the Sumylact L absorption carrier, immobilization technology is: resin demand is the outer free milk xylanase enzyme liquid of born of the same parents that every 1g resin adds 500 units, 50 ℃ of adsorption temps, vibration adsorption time 1 hour, leach the resin of adsorptive enzyme, add concentration and be in 1% the sodium alginate soln and stir, leach, place 0.6mol/L CaCl
2Soaked in the solution 5 minutes, and leached resin, add concentration again and be in 1% the glutaraldehyde, under 10 ℃ of temperature, left standstill crosslinked 4 hours.Measure the immobilized enzyme 93u/g of being alive, enzyme yield alive is 57.76%.
Test example 1 resin shaker test
Prepare the extracellular free milk xylanase according to Chinese patent application number for the disclosed method of patent application of CN 02108141.7; With different models such as D001, D001-CC, D061, D113, DA201, HPD600, HPD300, HPD100A, D202, pore diameter range is each 3g of macroporous resin of 80～200 , the Sumylact L liquid 3mL that adds 280.89u/mL respectively, under 20 ℃, vibration absorption 4 hours, measuring resin absorption fixed Sumylact L lives, calculate enzyme yield alive, the results are shown in Table 1.
Table 1 resin The selection result
Above-mentioned The selection result shows that the employing pore diameter range is that the adsorbed fixed Sumylact L of macroporous resin of 80～200 all has higher enzyme yield alive, and wherein preferred pore diameter range is the macroporous resin of 100～120 .
Test example 2 immobilized lactase catalysis lactose hydrolysis effect tests of the present invention
One, test materials
1, for test agent: the immobilized lactase that the embodiment of the invention 1 is prepared.
2, lactose solution: concentration is 50g/L.
Two, test method and result
Will be for the test agent lactose solution that is 50g/L in 30 ℃ of following conversion of substrate, the immobilized enzyme amount is 10% (g/100mL) of substrate solution, the transformation time curve sees Table 2.
Table 2 transformation time curve
Determine that transformation time is 1 hour, transform 52 batches repeatedly in batches, the results are shown in Table 3.
| Transformation time (h) | 0.5 | 1 | 1.5 | 2 | 6 | 9 | 24 |
| Residue lactose-content (g/L) | 18.14 | 8.11 | 4.15 | 2.30 | 0.36 | 0.27 | 0.15 |
| Lactose hydrolysis ratio (%) | 58.69 | 81.53 | 90.49 | 94.75 | 99.18 | 99.39 | 99.66 |
Table 3 immobilized enzyme of the present invention transforms the test-results of lactose solution repeatedly in batches
| Use batch | Residue lactose-content (g/L) | Lactose hydrolysis ratio (%) | Use batch | Residue lactose-content (g/L) | Lactose hydrolysis ratio (%) |
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 | 4.29 5.70 6.80 5.93 9.22 7.17 7.68 7.l0 7.50 7.74 7.54 8.35 11.97 7.70 8.14 8.73 7.37 9.67 7.98 7.74 7.34 8.38 7.73 8.06 9.02 8.10 | 91.29 88.42 86.18 87.95 81.26 85.43 84.38 85.56 84.76 84.27 84.68 83.02 75.67 84.34 83.46 82.26 85.02 80.35 83.78 84.27 85.08 82.98 84.30 83.61 81.67 83.54 | 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 | 8.52 8.86 8.71 8.51 9.83 14.24 7.57 9.62 9.01 10.23 9.69 9.36 9.61 9.98 11.43 9.65 6.41 10.33 8.81 10.39 9.90 6.49 9.34 9.62 10.04 11.74 | 82.69 81.99 82.29 82.71 80.01 71.06 84.60 80.45 81.68 76.69 77.92 78.69 78.10 77.27 73.96 78.03 85.40 76.48 79.94 76.33 77.45 85.21 78.72 78.09 77.14 73.26 |
Above-mentioned test-results shows that the immobilized lactase enzymic activity height that the present invention is prepared has higher hydrolyzes lactose efficient.
Test example 3
The immobilized lactase that embodiment 2 is prepared, 30 ℃ transform down milk (commercially available, the Bright brand fresh milk, down together), the immobilized enzyme amount is 10% (g/100mL) of milk consumption, lactose-content in different time sampling and measuring milk sample, and the transformation time curve sees Table 4.
Table 4 immobilized lactase transforms lactose-content variation in the milk process
| Transformation time (h) | 0 | 2 | 4 | 6 | 8 | 10 | 20 |
| Residue lactose-content (g/L) | 38.24 | 20.57 | 15.05 | 11.06 | 6.92 | 5.61 | 3.04 |
| Lactose hydrolysis ratio (%) | - | 46.59 | 60.92 | 71.29 | 82.03 | 85.43 | 92.12 |
Be 8 hours action time.Transform 30 batches repeatedly in batches, the results are shown in Table 5.
Table 5 immobilized lactase hydrolysed milk of the present invention 1-30 criticizes test-results
| Utilize batch | Lactose-content (g/L) | Lactose hydrolysis ratio (%) | Utilize batch | Lactose-content (g/L) | Lactose hydrolysis ratio (%) |
| 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | 40.52 1.81 5.47 9.54 12.90 3.93 12.27 18.65 10.89 11.56 10.38 15.00 10.51 14.72 11.95 15.84 | - 95.55 86.51 76.45 68.16 90.30 69.72 53.98 73.14 71.48 74.39 62.99 74.07 63.67 70.50 60.90 | 0 * 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 | 63.23 9.31 11.11 5.88 10.50 10.53 11.47 13.28 12.42 18.13 15.49 13.20 13.29 13.06 12.96 18.45 | 85.28 82.42 90.70 83.39 83.35 81.86 79.00 80.36 71.33 75.50 79.12 78.98 79.35 79.50 70.83 |
*Wherein the 16th batch begins to use instead the milk of newly purchasing.
Above-mentioned test-results shows that the immobilized lactase enzymic activity height that the present invention is prepared has higher percent hydrolysis for lactose in milk.
Test example 4
The immobilized lactase that embodiment 3 is prepared, 60 ℃ transform milk (commercially available, Bright brand fresh milk) down, and the immobilized enzyme amount is 100% (g/100mL) of milk consumption, and transformation time is 15 minutes, the results are shown in Table 6.
60 ℃ of following immobilized enzyme of table 6 transform milk
| Use batch | Lactose-content (g/L) | Lactose hydrolysis ratio (%) |
| 0 1 2 3 4 5 6 7 8 9 10 | 63.23 7.07 7.28 15.77 13.86 15.81 19.16 21.36 21.00 28.32 25.00 | - 88.81 88.49 75.06 78.08 74.99 69.69 66.21 66.79 55.22 60.45 |
Test example 5
The method of embodiment 1 is prepared immobilized lactase, transform milk (commercially available, Bright brand fresh milk) under 5 ℃～7 ℃, the immobilized enzyme amount is 100% (g/100mL) of milk consumption, and transformation time is 30 minutes, the results are shown in Table 7.
Immobilized enzyme transforms milk under table 7 low temperature
| Use batch | Lactose-content (g/L) | Lactose hydrolysis ratio (%) |
| 0 1 2 3 4 5 6 7 8 9 10 | 29.87 7.63 9.87 11.08 10.89 8.86 10.27 12.91 9.15 10.89 10.05 | - 74.46 66.95 62.91 63.53 70.33 65.63 56.77 69.35 63.55 66.34 |
Claims (6)
1. fixing method of free milk xylanase may further comprise the steps:
(1) prepares free milk xylanase by art methods;
(2) free milk xylanase is adsorbed on the macroporous resin that pore diameter range is 80-200 ;
(3) macroporous resin that will adsorb free milk xylanase soaks with sodium alginate soln, stirs, and leaches, and carries out embedding treatment with embedding reagent again;
(4) macroporous resin that passes through embedding treatment in the step (3) was descended crosslinked 1-4 hour at 4-20 ℃ with cross-linking reagent, leach, promptly get immobilized lactase.
2. according to the method for claim 1, it is characterized in that in the step (2) free milk xylanase being adsorbed on the macroporous resin that pore diameter range is 80-200 according to following condition: every 1g resin adds the Sumylact L liquid of 100-500 unit, adsorption temp is 10-50 ℃, and the vibration adsorption time is 1-4 hour.
3. according to the method for claim 1, the aperture that it is characterized in that the macroporous resin described in the step (2) is 100-120 .
4. according to the method for claim 1, the weight percent concentration that it is characterized in that the sodium alginate soln described in the step (3) is 1%-5%; Described embedding reagent is selected from CaCl
2Solution, carrageenin or gelatin.
5. according to the method for claim 4, it is characterized in that described embedding reagent is that concentration is the CaCl of 0.1-1.0mol/L
2Solution.
6. according to the method for claim 1, it is characterized in that the cross-linking reagent described in the step (4) is that concentration is the glutaraldehyde of 0.25%-2.5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100804920A CN1314800C (en) | 2005-07-06 | 2005-07-06 | Fixation method of microbiological lactase and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100804920A CN1314800C (en) | 2005-07-06 | 2005-07-06 | Fixation method of microbiological lactase and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1724662A CN1724662A (en) | 2006-01-25 |
| CN1314800C true CN1314800C (en) | 2007-05-09 |
Family
ID=35924292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100804920A Expired - Fee Related CN1314800C (en) | 2005-07-06 | 2005-07-06 | Fixation method of microbiological lactase and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1314800C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100366737C (en) * | 2006-03-01 | 2008-02-06 | 哈尔滨美华生物技术股份有限公司 | Production of curing lactase |
| CN101575135B (en) * | 2009-06-05 | 2011-12-21 | 上海大学 | Method for separating out phenols substances in water by catalytic oxidation with enzyme-carrying silicon-based mesoporous molecular sieve SBA-15 |
| CN108064936A (en) * | 2016-11-11 | 2018-05-25 | 内蒙古伊利实业集团股份有限公司 | A kind of preparation method for the liquid diary product for reducing Mei Lade products |
| CN111763666A (en) * | 2020-07-29 | 2020-10-13 | 安徽大学 | A kind of immobilization method of β-galactosidase and its application in preparing low-lactose milk |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037667A2 (en) * | 1980-04-04 | 1981-10-14 | Sumitomo Chemical Company, Limited | Immobilized lactase, its preparation and use |
| US4465772A (en) * | 1980-10-06 | 1984-08-14 | Sumitomo Chemical Company, Limited | Method for disinfecting and washing of immobilized lactase |
| CN2362866Y (en) * | 1999-02-11 | 2000-02-09 | 中国牧工商(集团)总公司 | Hyaluronic cell lactase hollow fibre biochemical reactor |
-
2005
- 2005-07-06 CN CNB2005100804920A patent/CN1314800C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037667A2 (en) * | 1980-04-04 | 1981-10-14 | Sumitomo Chemical Company, Limited | Immobilized lactase, its preparation and use |
| US4465772A (en) * | 1980-10-06 | 1984-08-14 | Sumitomo Chemical Company, Limited | Method for disinfecting and washing of immobilized lactase |
| CN2362866Y (en) * | 1999-02-11 | 2000-02-09 | 中国牧工商(集团)总公司 | Hyaluronic cell lactase hollow fibre biochemical reactor |
Non-Patent Citations (1)
| Title |
|---|
| 微生物乳糖酶的特性和发展现状 王敏等，河北农业大学学报，第26卷 2003 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1724662A (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Husain | β Galactosidases and their potential applications: a review | |
| AU723674B2 (en) | Process for producing N-acetyl-D-glucosamine | |
| CN101368195B (en) | Preparation method for high purity fructo-oligosaccharide | |
| Dal Magro et al. | Enzymatic clarification of orange juice in continuous bed reactors: Fluidized-bed versus packed-bed reactor | |
| Noreen et al. | Performance improvement of Ca-alginate bead cross-linked laccase from Trametes versicolor IBL-04 | |
| CN105950679B (en) | Method for preparing D-pantolactone by fermentation | |
| CN106520747A (en) | Novel immobilized enzyme preparation, and preparation method and application thereof | |
| CN101899484A (en) | Preparation method of genipin | |
| CN101491288A (en) | Soybean peptide preparation technique by microbe fermentation | |
| CN1314800C (en) | Fixation method of microbiological lactase and its application | |
| CN1111604C (en) | Process for preparing D-lactone valerate by microbe enzyme method | |
| CN102228125B (en) | Preparation method of algal active peptide | |
| CN103525803A (en) | Preparation method and application of natural material composite system immobilized bifunctional enzyme used for wine | |
| Núñez-Serrano et al. | Production and immobilization of pectinases from Penicillium crustosum in magnetic core-shell nanostructures for juice clarification | |
| US8852904B2 (en) | Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same | |
| CN1285403A (en) | Preparation of chitin microspheric immobilized papain | |
| CN101294157A (en) | A method for immobilizing laccase on porous silica gel | |
| CN105063008B (en) | It is a kind of using modification infusorial earth as immobilization brood cell's laccase of carrier and the preparation method and application thereof | |
| CN102994589A (en) | Method for preparing galactooligosaccharide by use of permeable cell beta-galactosidase | |
| CN108822206A (en) | A kind of biologically active cod collagen peptide | |
| CN104178475A (en) | Method for immobilizing microorganism bacteria | |
| CN116059975B (en) | Ammonia adsorption material prepared by oxidation modified keratin and preparation method and application thereof | |
| Başak et al. | Immobilization of catalase on chitosan and amino acid-modified chitosan beads | |
| CN101845465A (en) | Process for producing D(-)-tartaric acid by biotransformation | |
| Rossetto et al. | Application of Bentonite and Charcoal for the Purification of Pectinases From Aspergillus niger ATCC 9642 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070509 Termination date: 20160706 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |